StockData
LivaNova PLC logo

LivaNova PLC (LIVN) stock

LIVNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 13/3032% above fair value
$94.54+2.62 (+2.85%)

Close on Nov 18, 2026Market cap $5.21BP/E 27.9Yield –

LivaNova total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

LivaNova's total debt was $293.49M at Jun 30, 2026. For fiscal 2025 it was $376.66M, down 40.0% from the year before. The highest annual figure on record is $655.64M in fiscal 2020.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$376.66M-40.0%
FY2024Dec 31, 2024$627.63M+7.0%
FY2023Dec 31, 2023$586.65M+8.3%
FY2022Dec 31, 2022$541.50M+126.1%
FY2021Dec 31, 2021$239.52M-63.5%
FY2020Dec 31, 2020$655.64M+94.1%
FY2019Dec 31, 2019$337.73M+100.6%
FY2018Dec 31, 2018$168.33M+15.3%
FY2017Dec 31, 2017$145.99M–
FY2015Apr 24, 2015$0–
FY2014Apr 25, 2014$0–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$293.49M-31.8%
Q1 FY2026CQ1 2026Mar 31, 2026$287.79M-54.2%
Q4 FY2025CQ4 2025Dec 31, 2025$376.66M-40.0%
Q3 FY2025CQ3 2025Sep 30, 2025$434.47M-30.6%
Q2 FY2025CQ2 2025Jun 30, 2025$430.62M-31.1%
Q1 FY2025CQ1 2025Mar 31, 2025$628.79M+0.7%
Q4 FY2024CQ4 2024Dec 31, 2024$627.63M+7.0%
Q3 FY2024CQ3 2024Sep 30, 2024$626.24M+6.6%
Q2 FY2024CQ2 2024Jun 30, 2024$625.17M+6.5%
Q1 FY2024CQ1 2024Mar 31, 2024$624.46M+15.1%
Q4 FY2023CQ4 2023Dec 31, 2023$586.65M+8.3%
Q3 FY2023CQ3 2023Sep 30, 2023$587.19M+8.8%
Q2 FY2023CQ2 2023Jun 30, 2023$587.03M+26.0%
Q1 FY2023CQ1 2023Mar 31, 2023$542.50M+17.8%
Q4 FY2022CQ4 2022Dec 31, 2022$541.50M+126.1%
Q3 FY2022CQ3 2022Sep 30, 2022$539.94M+126.3%
Q2 FY2022CQ2 2022Jun 30, 2022$466.03M-29.7%
Q1 FY2022CQ1 2022Mar 31, 2022$460.56M-30.0%
Q4 FY2021CQ4 2021Dec 31, 2021$239.52M-63.5%
Q3 FY2021CQ3 2021Sep 30, 2021$238.57M-63.4%
Q2 FY2021CQ2 2021Jun 30, 2021$663.05M+2.5%
Q1 FY2021CQ1 2021Mar 31, 2021$658.16M+22.1%
Q4 FY2020CQ4 2020Dec 31, 2020$655.64M+94.1%
Q3 FY2020CQ3 2020Sep 30, 2020$651.06M+90.6%
Q2 FY2020CQ2 2020Jun 30, 2020$646.64M+204.9%
Q1 FY2020CQ1 2020Mar 31, 2020$538.88M+197.2%
Q4 FY2019CQ4 2019Dec 31, 2019$337.73M+100.6%
Q3 FY2019CQ3 2019Sep 30, 2019$341.66M+117.5%
Q2 FY2019CQ2 2019Jun 30, 2019$212.10M+31.7%
Q1 FY2019CQ1 2019Mar 31, 2019$181.29M-1.1%
Q4 FY2018CQ4 2018Dec 31, 2018$168.33M+15.3%
Q3 FY2018CQ3 2018Sep 30, 2018$157.07M+26.7%
Q2 FY2018CQ2 2018Jun 30, 2018$161.00M+28.3%
Q1 FY2018CQ1 2018Mar 31, 2018$183.36M+50.9%
Q4 FY2017CQ4 2017Dec 31, 2017$145.99M–
Q3 FY2017CQ3 2017Sep 30, 2017$123.93M–
Q2 FY2017CQ2 2017Jun 30, 2017$125.52M–
Q1 FY2017CQ1 2017Mar 31, 2017$121.52M–
Q4 FY2015CQ1 2015Apr 24, 2015$0–

More LivaNova figures

See a number that looks wrong?